Eva Lengfelder
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 58
- Acute Myeloid Leukemia Research 44
- Chronic Myeloid Leukemia Treatments 12
- Genetics 44
- Chronic Lymphocytic Leukemia Research 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 20
- Co-authors
- Wolfgang HiddemannThomas BüchnerHartmut DöhnerDavid GrimwadeTorsten HaferlachClaudia SchochFrancesco Lo‐CocoPierre Fenaux
- Journals
- Blood (29 papers)Journal of Clinical Oncology (9 papers)Annals of Hematology (8 papers)British Journal of Haematology (5 papers)Leukemia Research (3 papers)
- Partner nations
- GermanyUnited KingdomItaly
In The Last Decade
Eva Lengfelder
92 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 2.6k
- Genetics 1.6k
- Pathology and Forensic Medicine 727
- Rheumatology 507
- Biochemistry 185
Countries citing papers authored by Eva Lengfelder
This map shows the geographic impact of Eva Lengfelder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Lengfelder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Lengfelder more than expected).
Fields of papers citing papers by Eva Lengfelder
This network shows the impact of papers produced by Eva Lengfelder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Lengfelder. The network helps show where Eva Lengfelder may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Lengfelder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 4 | |
| 2 | 2013 | 7 | |
| 3 | 2013 | 16 | |
| 4 | 2011 | 30 | |
| 5 | 2011 | 132 | |
| 6 | 2008 | 232 | |
| 7 | 2007 | 35 | |
| 8 | 2006 | 80 | |
| 9 | 2006 | 67 | |
| 10 | 2006 | 4 | |
| 11 | 2006 | 56 | |
| 12 | Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG) | 2005 | 18 |
| 13 | 2004 | 51 | |
| 14 | 2004 | 26 | |
| 15 | 2000 | 1 | |
| 16 | 1998 | 87 | |
| 17 | 1995 | 68 | |
| 18 | 1993 | 22 | |
| 19 | 1992 | 3 | |
| 20 | 1987 | 1 |
About Eva Lengfelder
Eva Lengfelder is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Biochemistry and Rheumatology, having authored 95 papers that have together received 4.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (44 papers), Retinoids in leukemia and cellular processes (26 papers), Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers), Acute Lymphoblastic Leukemia research (15 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Eosinophilic Disorders and Syndromes (10 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (1.6k citations), Pathology and Forensic Medicine (727 citations), Rheumatology (507 citations) and Biochemistry (185 citations). Eva Lengfelder has collaborated with scholars based in Germany, United Kingdom and Italy. Frequent co-authors include Wolfgang Hiddemann, Thomas Büchner, Hartmut Döhner, David Grimwade, Torsten Haferlach, Thomas Büchner, Claudia Schoch, Francesco Lo‐Coco, Pierre Fenaux and Martin Grießhammer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, British Journal of Haematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.